Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks
Abstract Tuberculosis (TB) is a leading infectious disease killer and one of the major causes of deaths worldwide. Although TB is a curable and preventable disease, in 2023, approximately 10.8 million people fell ill with TB and there were an estimated 1.25 million of deaths worldwide. Despite some...
Saved in:
| Main Authors: | Luana Layse Câmara de Almeida, Sayoane Pessoa Fernandes, Genil Dantas de Oliveira, Marcelly da Silveira Silva, Thalisson Amorim de Souza, Valnês S. Rodrigues-Junior, Samuel Paulo Cibulski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-08-01
|
| Series: | Natural Products and Bioprospecting |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13659-025-00533-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolites Discovery from <i>Streptomyces xanthus</i>: Exploring the Potential of Desert Microorganisms
by: Xinrong Luo, et al.
Published: (2025-02-01) -
Synthesis of novel triazole hybrids with pyrene, fluorene, and biphenyl groups and evaluation of their antimycobacterial activity
by: Goyal Akshi, et al.
Published: (2025-07-01) -
Unraveling growth-promoting potential of plant beneficial actinobacteria on tropical bryophytes
by: Mathurin Meethangdee, et al.
Published: (2024-01-01) -
Secondary Metabolites from Marine Microorganisms. I. Secondary Metabolites from Marine Actinomycetes
by: T. I. Orlova, et al.
Published: (2020-05-01) -
Antifungal Metabolites from High-Altitude Soil Actinomycetes Isolated from Nepal
by: Sagar Aryal, et al.
Published: (2025-07-01)